There is the inbetween option of taking the drug through one or more phase 3s and then licensing without going all the way to market. In that case the responsibility for distribution would fall on who they licensed to and the deal would be more sizeable having progressed the compound further. I think that would be what Neuren are thinking as taking on the distribution aspect is a big step that current management aren't likely to have any experience.
- Forums
- ASX - By Stock
- Neuren Media and Analyst Coverage
There is the inbetween option of taking the drug through one or...
-
-
- There are more pages in this discussion • 133 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.39 |
Change
-0.470(2.37%) |
Mkt cap ! $2.478B |
Open | High | Low | Value | Volume |
$19.70 | $19.77 | $19.28 | $10.38M | 534.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2680 | $19.35 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.41 | 362 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2680 | 19.350 |
1 | 1365 | 19.320 |
3 | 2436 | 19.310 |
2 | 4246 | 19.300 |
5 | 2474 | 19.290 |
Price($) | Vol. | No. |
---|---|---|
19.410 | 362 | 1 |
19.490 | 1365 | 1 |
19.500 | 24 | 1 |
19.520 | 1365 | 1 |
19.540 | 1180 | 2 |
Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online